Literature DB >> 12060539

[Analysis of mutations in genes BRCA1 and BRCA2 among patients with breast and ovarian cancer in northern Portugal and Galicia].

F Duarte1, J F Cameselle-Teijeiro, R Soares, C Seixas, M E Cortizo-Torres, J Pérez-Villanueva, F C Schmitt.   

Abstract

OBJECTIVE: To detect mutations in the BRCA1 and BRCA2 genes by means of the protein truncation test (PTT) in a population in northern Portugal and Galicia with breast and ovarian cancer.
DESIGN: Prospective study.
SETTING: Patients in northern Portugal and Galicia with family history of breast and/or ovarian cancer.Patients. A total of 76 women with family history of breast cancer according to the BCLC criteria (Breast Cancer Linkage Consortium) were studied at IPATIMUP. MAIN
RESULTS: Five cases (6.5%) with changes in the normal sequence in genes BRCA1 and BRCA2 were identified; three of these mutations occurred in the gene BRCA1 and the other two in the gene BRCA2. Two out of the three mutations found in the gene BRCA1 were de novo mutations. Changes detected in the normal sequence in the gene BRCA2 were mutations reported for the first time among the study population, according to the information obtained through the BCIC database (Breast Cancer Information Core).
CONCLUSIONS: This was the first study in detecting individuals carrying mutations in the susceptibility breast cancer genes BRCA1 and BRCA2 among the population of northern Portugal and Galicia.

Entities:  

Mesh:

Year:  2002        PMID: 12060539     DOI: 10.1016/s0014-2565(02)71047-3

Source DB:  PubMed          Journal:  Rev Clin Esp        ISSN: 0014-2565            Impact factor:   1.556


  2 in total

1.  BRCA1 and BRCA2 germline mutational spectrum and evidence for genetic anticipation in Portuguese breast/ovarian cancer families.

Authors:  Ana Peixoto; Natália Salgueiro; Catarina Santos; Graça Varzim; Patrícia Rocha; Maria José Soares; Deolinda Pereira; Helena Rodrigues; Maria José Bento; António Fráguas; Graça Moura; Fernando Regateiro; Sérgio Castedo; Manuel R Teixeira
Journal:  Fam Cancer       Date:  2006-07-07       Impact factor: 2.375

2.  Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer.

Authors:  Sandra Costa; Daniela Pinto; Deolinda Pereira; Helena Rodrigues; Jorge Cameselle-Teijeiro; Rui Medeiros; Fernando Schmitt
Journal:  BMC Cancer       Date:  2008-01-29       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.